Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to $46.0 million.

  • Dr Reddys Laboratories' Other Non-Current Assets changed N/A to $46.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.0 million, marking a year-over-year change of. This contributed to the annual value of $12.0 million for FY2025, which is 4000.0% down from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Other Non-Current Assets stood at $46.0 million.
  • In the past 5 years, Dr Reddys Laboratories' Other Non-Current Assets ranged from a high of $64.4 million in Q3 2023 and a low of $59.01 during Q2 2022
  • Moreover, its 5-year median value for Other Non-Current Assets was $33.1 million (2021), whereas its average is $32.0 million.
  • In the last 5 years, Dr Reddys Laboratories' Other Non-Current Assets plummeted by 9999.98% in 2022 and then surged by 9307211832.3% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Other Non-Current Assets (Quarter) stood at $31.0 million in 2021, then soared by 84.09% to $57.1 million in 2022, then increased by 12.8% to $64.4 million in 2023, then plummeted by 72.0% to $18.0 million in 2024, then skyrocketed by 154.93% to $46.0 million in 2025.
  • Its Other Non-Current Assets was $46.0 million in Q4 2025, compared to $12.3 million in Q3 2025 and $45.6 million in Q1 2025.